209 related articles for article (PubMed ID: 17173931)
1. Intermolecular interactions and characterization of the novel factor Xa exosite involved in macromolecular recognition and inhibition: crystal structure of human Gla-domainless factor Xa complexed with the anticoagulant protein NAPc2 from the hematophagous nematode Ancylostoma caninum.
Murakami MT; Rios-Steiner J; Weaver SE; Tulinsky A; Geiger JH; Arni RK
J Mol Biol; 2007 Feb; 366(2):602-10. PubMed ID: 17173931
[TBL] [Abstract][Full Text] [Related]
2. Active and exo-site inhibition of human factor Xa: structure of des-Gla factor Xa inhibited by NAP5, a potent nematode anticoagulant protein from Ancylostoma caninum.
Rios-Steiner JL; Murakami MT; Tulinsky A; Arni RK
J Mol Biol; 2007 Aug; 371(3):774-86. PubMed ID: 17588602
[TBL] [Abstract][Full Text] [Related]
3. Ancylostoma ceylanicum anticoagulant peptide-1: role of the predicted reactive site amino acid in mediating inhibition of coagulation factors Xa and VIIa.
Mieszczanek J; Harrison LM; Cappello M
Mol Biochem Parasitol; 2004 Sep; 137(1):151-9. PubMed ID: 15279961
[TBL] [Abstract][Full Text] [Related]
4. The tissue factor/factor VIIa/factor Xa complex: a model built by docking and site-directed mutagenesis.
Norledge BV; Petrovan RJ; Ruf W; Olson AJ
Proteins; 2003 Nov; 53(3):640-8. PubMed ID: 14579355
[TBL] [Abstract][Full Text] [Related]
5. Nematode anticoagulant protein c2 reveals a site on factor Xa that is important for macromolecular substrate binding to human prothrombinase.
Buddai SK; Toulokhonova L; Bergum PW; Vlasuk GP; Krishnaswamy S
J Biol Chem; 2002 Jul; 277(29):26689-98. PubMed ID: 12011050
[TBL] [Abstract][Full Text] [Related]
6. Inherent flexibility in a potent inhibitor of blood coagulation, recombinant nematode anticoagulant protein c2.
Duggan BM; Dyson HJ; Wright PE
Eur J Biochem; 1999 Oct; 265(2):539-48. PubMed ID: 10504384
[TBL] [Abstract][Full Text] [Related]
7. The role of catalytic cleft and exosite residues of factor VIIa for complex formation with tissue factor pathway inhibitor.
Iakhiaev A; Ruf W; Rao LV
Thromb Haemost; 2001 Mar; 85(3):458-63. PubMed ID: 11307815
[TBL] [Abstract][Full Text] [Related]
8. Ancylostoma caninum anticoagulant peptide blocks metastasis in vivo and inhibits factor Xa binding to melanoma cells in vitro.
Donnelly KM; Bromberg ME; Milstone A; Madison McNiff JM; Terwilliger G; Konigsberg WH; Cappello M
Thromb Haemost; 1998 May; 79(5):1041-7. PubMed ID: 9609244
[TBL] [Abstract][Full Text] [Related]
9. The quest for Factor VIIa exosite inhibitors.
Amour A; Hutchinson J; Ruiz Avendaño AM; Ratcliffe S; Alvarez E; Martin J; Toomey JR; Senger S; Wolfendale M; Mooney C
Biochem Soc Trans; 2007 Jun; 35(Pt 3):555-8. PubMed ID: 17511650
[TBL] [Abstract][Full Text] [Related]
10. Phospholipid regulates the activation of factor X by tissue factor/factor VIIa (TF/VIIa) via substrate and product interactions.
Hathcock JJ; Rusinova E; Gentry RD; Andree H; Nemerson Y
Biochemistry; 2005 Jun; 44(22):8187-97. PubMed ID: 15924438
[TBL] [Abstract][Full Text] [Related]
11. Changes in Internal Structure and Dynamics upon Binding Stabilise the Nematode Anticoagulant NAPc2.
Woodward E; Duggan BM
Biomolecules; 2024 Mar; 14(4):. PubMed ID: 38672438
[TBL] [Abstract][Full Text] [Related]
12. Co-crystal structure and inhibition of factor Xa by PD0313052 identifies structurally stabilized active site residues of factor Xa and prothrombinase.
Gould WR; Cladera E; Harris MS; Zhang E; Narasimhan L; Thorn JM; Leadley RJ
Biochemistry; 2005 Jul; 44(26):9280-9. PubMed ID: 15981994
[TBL] [Abstract][Full Text] [Related]
13. The crystal structure of the complex of blood coagulation factor VIIa with soluble tissue factor.
Banner DW; D'Arcy A; Chène C; Winkler FK; Guha A; Konigsberg WH; Nemerson Y; Kirchhofer D
Nature; 1996 Mar; 380(6569):41-6. PubMed ID: 8598903
[TBL] [Abstract][Full Text] [Related]
14. Importance of factor VIIa Gla-domain residue Arg-36 for recognition of the macromolecular substrate factor X Gla-domain.
Ruf W; Shobe J; Rao SM; Dickinson CD; Olson A; Edgington TS
Biochemistry; 1999 Feb; 38(7):1957-66. PubMed ID: 10026279
[TBL] [Abstract][Full Text] [Related]
15. The second Kunitz domain of human tissue factor pathway inhibitor: cloning, structure determination and interaction with factor Xa.
Burgering MJ; Orbons LP; van der Doelen A; Mulders J; Theunissen HJ; Grootenhuis PD; Bode W; Huber R; Stubbs MT
J Mol Biol; 1997 Jun; 269(3):395-407. PubMed ID: 9199408
[TBL] [Abstract][Full Text] [Related]
16. Unexpected binding mode of tick anticoagulant peptide complexed to bovine factor Xa.
Wei A; Alexander RS; Duke J; Ross H; Rosenfeld SA; Chang CH
J Mol Biol; 1998; 283(1):147-54. PubMed ID: 9761680
[TBL] [Abstract][Full Text] [Related]
17. A loop of coagulation factor VIIa influencing macromolecular substrate specificity.
Bjelke JR; Persson E; Rasmussen HB; Kragelund BB; Olsen OH
FEBS Lett; 2007 Jan; 581(1):71-6. PubMed ID: 17182039
[TBL] [Abstract][Full Text] [Related]
18. Inhibitors of factor VIIa affect the interface between the protease domain and tissue factor.
Carlsson K; Persson E; Carlsson U; Svensson M
Biochem Biophys Res Commun; 2006 Oct; 349(3):1111-6. PubMed ID: 16970919
[TBL] [Abstract][Full Text] [Related]
19. An all-atom solution-equilibrated model for human extrinsic blood coagulation complex (sTF-VIIa-Xa): a protein-protein docking and molecular dynamics refinement study.
Venkateswarlu D; Duke RE; Perera L; Darden TA; Pedersen LG
J Thromb Haemost; 2003 Dec; 1(12):2577-88. PubMed ID: 14750502
[TBL] [Abstract][Full Text] [Related]
20. Peptide exosite inhibitors of factor VIIa as anticoagulants.
Dennis MS; Eigenbrot C; Skelton NJ; Ultsch MH; Santell L; Dwyer MA; O'Connell MP; Lazarus RA
Nature; 2000 Mar; 404(6777):465-70. PubMed ID: 10761907
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
